Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
Mickaël Burgy(Centre National de la Recherche Scientifique), Sophie Martin(Centre National de la Recherche Scientifique)
Cited by 12
Related Papers
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
|Cells|2023|30
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids
|International Journal of Molecular Sciences|2023|12